Fig. 7

Adhesion and migration assays. Quantification of adherence capacity (number of attached cells) for (a) HT29 and (b) HCT116 cell lines after 48 h treatment with 5-FU and/or Olaparib (n = 3). *p < 0.05, **p < 0.01, ***p < 0.001 and ****p < 0.0001 next to symbols vs. untreated control at the same timepoint; ^#p < 0.05 vs. 5-FU monotherapy in the same concentration at the same timepoint. c Representative images of migration capacity assay for HT29 and HCT116 cell lines after 48hs treatment with 5FU and/or Olaparib (n = 3). d Quantification of migrated cells for HT29 and HCT116 cell lines after 48hs treatment with 5FU and/or Olaparib. Untreated cells were used as negative control. *p < 0.05, **p < 0.01 and ***p < 0.001 above error bars vs. untreated control; ^#p < 0.05 vs. 5-FU monotherapy in the same concentration. Two-way ANOVA and Tukey’s post hoc tests